Eliem Therapeutics, Inc.ELYMNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-82.02M
↓ 131% below average
Average (5y)
$-35.44M
Historical baseline
Range
High:$-7.45M
Low:$-82.02M
CAGR
+61.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-82.02M | -282.1% |
| 2023 | $-21.47M | +52.4% |
| 2022 | $-45.13M | -26.5% |
| 2021 | $-35.67M | -70.5% |
| 2020 | $-20.93M | -181.0% |
| 2019 | $-7.45M | - |